Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China
The association between Toxoplasma gondii (T. gondii) infection and malignancy has attracted increased attention in recent years, but little is known of T. gondii infection among women diagnosed with a gynecological tumor (GT) in China. We conducted a case-control study involving 460 women diagnosed...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2022-12-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/14569.pdf |
| _version_ | 1827607771019739136 |
|---|---|
| author | Zhongjun Wang Tingting Qu Huiyang Qi Shuchao Zhao Hailei Shi Wenye Bai Yang Yu Xiao Wu Peng Zhao |
| author_facet | Zhongjun Wang Tingting Qu Huiyang Qi Shuchao Zhao Hailei Shi Wenye Bai Yang Yu Xiao Wu Peng Zhao |
| author_sort | Zhongjun Wang |
| collection | DOAJ |
| description | The association between Toxoplasma gondii (T. gondii) infection and malignancy has attracted increased attention in recent years, but little is known of T. gondii infection among women diagnosed with a gynecological tumor (GT) in China. We conducted a case-control study involving 460 women diagnosed with a GT and 460 age-matched healthy controls (HCs) to estimate the infection process of T. gondii and understand the risk factors of T. gondii infection in patients with a GT. Levels of anti-T. gondii IgG and IgM were measured by enzyme-linked immunoassays every 12 months. After a median follow-up time of 4.3 years (range 4 to 5 years), 55/460 (11.96%) patients with a GT and 15/460 (3.26%) HCs were seroprevalence for T. gondii antibodies, respectively (P = 0.001). IgG antibodies against T. gondii were found in 54 GT patients (11.74%) and 15 HCs (3.26%), respectively (P = 0.001). The seroprevalence of T. gondii IgM antibodies was similar in patients with a GT and with HCs (2.83% vs 1.3%, P = 0.105). Multivariate stepwise logistic regression analysis revealed contact with cats (OR, 6.67; 95% CI [2.89–10.75]; P = 0.001), exposure to soil (OR, 2.16; 95% CI [1.14–4.10]; P = 0.019), being a farm-worker (OR, 4.17; 95% CI [1.20–11.49]; P = 0.006) and history of chemotherapy (OR, 3.16; 95% CI [1.56–6.45]; P = 0.001) to be independent risk factors for T. gondii infection. Women with an ovarian cancer or endometrial cancer had higher T. gondii seroprevalence than that of HCs. Moreover, T. gondii infection in patients with a GT mostly acquired within two years of diagnosis, but the infection in healthy controls had no obvious time characteristics. Here, we demonstrated that T. gondii infection is significantly higher in patients with a GT (especially in women with an ovarian tumor) compared to HCs. Thus, infection with this parasite should be avoided in patients with a GT, and the causal relationship between T. gondii and GTs should be studied in detail. |
| first_indexed | 2024-03-09T07:00:16Z |
| format | Article |
| id | doaj.art-93fd3e9d54624b32a7b02dfca604b338 |
| institution | Directory Open Access Journal |
| issn | 2167-8359 |
| language | English |
| last_indexed | 2024-03-09T07:00:16Z |
| publishDate | 2022-12-01 |
| publisher | PeerJ Inc. |
| record_format | Article |
| series | PeerJ |
| spelling | doaj.art-93fd3e9d54624b32a7b02dfca604b3382023-12-03T09:54:47ZengPeerJ Inc.PeerJ2167-83592022-12-0110e1456910.7717/peerj.14569Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern ChinaZhongjun Wang0Tingting Qu1Huiyang Qi2Shuchao Zhao3Hailei Shi4Wenye Bai5Yang Yu6Xiao Wu7Peng Zhao8Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Hepatobilary and Surgery Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Clinical Laboratory, Qingdao Women and Children’s Hospital, Qingdao, Shandong, ChinaDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaThe association between Toxoplasma gondii (T. gondii) infection and malignancy has attracted increased attention in recent years, but little is known of T. gondii infection among women diagnosed with a gynecological tumor (GT) in China. We conducted a case-control study involving 460 women diagnosed with a GT and 460 age-matched healthy controls (HCs) to estimate the infection process of T. gondii and understand the risk factors of T. gondii infection in patients with a GT. Levels of anti-T. gondii IgG and IgM were measured by enzyme-linked immunoassays every 12 months. After a median follow-up time of 4.3 years (range 4 to 5 years), 55/460 (11.96%) patients with a GT and 15/460 (3.26%) HCs were seroprevalence for T. gondii antibodies, respectively (P = 0.001). IgG antibodies against T. gondii were found in 54 GT patients (11.74%) and 15 HCs (3.26%), respectively (P = 0.001). The seroprevalence of T. gondii IgM antibodies was similar in patients with a GT and with HCs (2.83% vs 1.3%, P = 0.105). Multivariate stepwise logistic regression analysis revealed contact with cats (OR, 6.67; 95% CI [2.89–10.75]; P = 0.001), exposure to soil (OR, 2.16; 95% CI [1.14–4.10]; P = 0.019), being a farm-worker (OR, 4.17; 95% CI [1.20–11.49]; P = 0.006) and history of chemotherapy (OR, 3.16; 95% CI [1.56–6.45]; P = 0.001) to be independent risk factors for T. gondii infection. Women with an ovarian cancer or endometrial cancer had higher T. gondii seroprevalence than that of HCs. Moreover, T. gondii infection in patients with a GT mostly acquired within two years of diagnosis, but the infection in healthy controls had no obvious time characteristics. Here, we demonstrated that T. gondii infection is significantly higher in patients with a GT (especially in women with an ovarian tumor) compared to HCs. Thus, infection with this parasite should be avoided in patients with a GT, and the causal relationship between T. gondii and GTs should be studied in detail.https://peerj.com/articles/14569.pdfToxoplasma gondiiGynecological tumorSeroprevalence |
| spellingShingle | Zhongjun Wang Tingting Qu Huiyang Qi Shuchao Zhao Hailei Shi Wenye Bai Yang Yu Xiao Wu Peng Zhao Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China PeerJ Toxoplasma gondii Gynecological tumor Seroprevalence |
| title | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
| title_full | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
| title_fullStr | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
| title_full_unstemmed | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
| title_short | Seroprevalence of Toxoplasma gondii infection in women with a gynecological tumor living in eastern China |
| title_sort | seroprevalence of toxoplasma gondii infection in women with a gynecological tumor living in eastern china |
| topic | Toxoplasma gondii Gynecological tumor Seroprevalence |
| url | https://peerj.com/articles/14569.pdf |
| work_keys_str_mv | AT zhongjunwang seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT tingtingqu seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT huiyangqi seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT shuchaozhao seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT haileishi seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT wenyebai seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT yangyu seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT xiaowu seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina AT pengzhao seroprevalenceoftoxoplasmagondiiinfectioninwomenwithagynecologicaltumorlivingineasternchina |